Glutamate and dopamine in schizophrenia: An update for the 21st century
O Howes, R McCutcheon… - Journal of …, 2015 - journals.sagepub.com
The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of
schizophrenia. Both were initially based on indirect evidence from pharmacological studies …
schizophrenia. Both were initially based on indirect evidence from pharmacological studies …
A review of reward processing and motivational impairment in schizophrenia
This article reviews and synthesizes research on reward processing in schizophrenia, which
has begun to provide important insights into the cognitive and neural mechanisms …
has begun to provide important insights into the cognitive and neural mechanisms …
[HTML][HTML] Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
MJ Millan, K Fone, T Steckler, WP Horan - European …, 2014 - Elsevier
Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults
at the time of the first psychotic episode of delusions and hallucinations. These positive …
at the time of the first psychotic episode of delusions and hallucinations. These positive …
Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis
Importance Abnormal reward processing is suggested to underlie the formation of psychotic
symptoms, likely driven by elevated ventral striatal (VS) dopamine levels. Functional …
symptoms, likely driven by elevated ventral striatal (VS) dopamine levels. Functional …
An integrative perspective on the role of dopamine in schizophrenia
We propose that schizophrenia involves a combination of decreased phasic dopamine
responses for relevant stimuli and increased spontaneous phasic dopamine release. Using …
responses for relevant stimuli and increased spontaneous phasic dopamine release. Using …
The link between schizophrenia and substance use disorder: A unifying hypothesis
Substance use disorders occur commonly in patients with schizophrenia and dramatically
worsen their overall clinical course. While the exact mechanisms contributing to substance …
worsen their overall clinical course. While the exact mechanisms contributing to substance …
The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs
A range of emotional and motivation impairments have long been clinically documented in
people with schizophrenia, and there has been a resurgence of interest in understanding …
people with schizophrenia, and there has been a resurgence of interest in understanding …
Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia
Importance Previous evidence has implicated corticostriatal abnormalities in the
pathophysiology of psychosis. Although the striatum is the primary target of all efficacious …
pathophysiology of psychosis. Although the striatum is the primary target of all efficacious …
Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task
J Zeng, J Yan, H Cao, Y Su, Y Song, Y Luo… - Translational …, 2022 - nature.com
Dysfunction of the mesocorticolimbic dopaminergic reward system is a core feature of
schizophrenia (SZ), yet its precise contributions to different stages of reward processing and …
schizophrenia (SZ), yet its precise contributions to different stages of reward processing and …
A transdiagnostic review of negative symptom phenomenology and etiology
In the DSM5, negative symptoms are 1 of the 5 core dimensions of psychopathology
evaluated for schizophrenia. However, negative symptoms are not pathognomonic—they …
evaluated for schizophrenia. However, negative symptoms are not pathognomonic—they …